210 related articles for article (PubMed ID: 15887857)
1. Risk factors associated to kidney stones in primary hyperparathyroidism.
Corbetta S; Baccarelli A; Aroldi A; Vicentini L; Fogazzi GB; Eller-Vainicher C; Ponticelli C; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2005 Feb; 28(2):122-8. PubMed ID: 15887857
[TBL] [Abstract][Full Text] [Related]
2. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
4. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of primary hyperparathyroidism with and without kidney stones.
Odvina CV; Sakhaee K; Heller HJ; Peterson RD; Poindexter JR; Padalino PK; Pak CY
Urol Res; 2007 Jun; 35(3):123-8. PubMed ID: 17476495
[TBL] [Abstract][Full Text] [Related]
6. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
7. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. I. Hypercalciuria].
Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
Pol Arch Med Wewn; 1992 Jan; 87(1):41-8. PubMed ID: 1641363
[TBL] [Abstract][Full Text] [Related]
8. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
Perez AA; Schneider DF; Long KL; Pitt SC; Sippel RS
J Surg Res; 2018 Dec; 232():564-569. PubMed ID: 30463775
[TBL] [Abstract][Full Text] [Related]
9. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
[TBL] [Abstract][Full Text] [Related]
10. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.
Pak CY; Holt K
Metabolism; 1976 Jun; 25(6):665-73. PubMed ID: 1272073
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
Parks JH; Coe FL; Evan AP; Worcester EM
BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
[TBL] [Abstract][Full Text] [Related]
12. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
[TBL] [Abstract][Full Text] [Related]
13. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers.
Prochaska ML; Moe OW; Asplin JR; Coe FL; Worcester EM
Physiol Rep; 2021 Jul; 9(13):e14943. PubMed ID: 34231328
[TBL] [Abstract][Full Text] [Related]
14. Primary hyperparathyroidism. A cause of hypercalciuria and renal stones in patients with medullary sponge kidney.
Rao DS; Frame B; Block MA; Parfitt AM
JAMA; 1977 Mar; 237(13):1353-5. PubMed ID: 576483
[TBL] [Abstract][Full Text] [Related]
15. Essential arterial hypertension and stone disease.
Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
[TBL] [Abstract][Full Text] [Related]
16. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratory parameters in patients with urolithiasis in the presence and absence of primary hyperparathyroidism].
Dzerganov NK; Egshatian LV; Mokrysheva NG; Peretokina EV
Urologiia; 2013; (6):14-8. PubMed ID: 24649757
[TBL] [Abstract][Full Text] [Related]
18. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism.
Corbetta S; Eller-Vainicher C; Frigerio M; Valaperta R; Costa E; Vicentini L; Baccarelli A; Beck-Peccoz P; Spada A
Eur J Endocrinol; 2009 Feb; 160(2):283-8. PubMed ID: 19029225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
